Background The use of warfarin sodium for treating venous thromboembolism in patients
with cancer is associated with a significant risk of recurrence and bleeding. The use of low-…

Background The addition of bevacizumab to chemotherapy improves progression-free survival
in metastatic breast cancer and pathological complete response rates in the neoadjuvant …

Although there is evidence that redox regulation has an essential role in malignancies, its
impact on tumor prognosis remains unclear. Here we show crosstalk between oxidative stress …

Instability of microsatellites is a hallmark of the DNA replication error phenotype (RER+) due
to the inactivation of mismatch repair genes. In humans, microsatellite instability has first …

Background We conducted a meta-analysis in nonmetastatic breast cancer patients treated
by neoadjuvant chemotherapy (NCT) to assess the clinical validity of circulating tumor cell (…

BACKGROUND In nonmetastatic triple-negative breast cancer (TNBC) patients, we
investigated whether circulating tumor DNA (ctDNA) detection can reflect the tumor response to …

Background Palbociclib is a CDK4/6 inhibitor with demonstrated efficacy and safety in
combination with endocrine therapy in advanced luminal breast cancer (LBC). We evaluated the …

Introduction Identification of new therapeutic agents for breast cancer (BC) requires preclinical
models that reproduce the molecular characteristics of their respective clinical tumors. In …

Case 1: A 58-year-old woman presented with node-negative, high-grade, hormone receptor
(HR)-negative, invasive breast ductal carcinoma. HER2 overexpression was observed in …

Resistance to endocrine treatments and CDK4/6 inhibitors is considered a near-inevitability
in most patients with estrogen receptor positive breast cancers (ER + BC). By genomic and …